Search research articles
Contact Us
Filters
Showing results (61-70 of 67) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 67 results.
Journal of Viral Hepatitis
|
January 14, 2012
Peginterferon alfa-2b plus weight-based ribavirin for 24 weeks in patients with chronic hepatitis C virus genotype 1 with low viral load who achieve rapid viral response
A Craxi, S Koutsounas, P Ogurtsov, et al.
Gastroenterology
|
July 27, 1999
Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: analysis of individual patient data of six controlled trials. Eurohep Study Group for Viral Hepatitis
S W Schalm, O Weiland, B E Hansen, et al.
Journal of Viral Hepatitis
|
March 1, 1997
Treatment of chronic hepatitis C with interferon-alpha by monitoring the response according to viraemia
P Bonetti, L Chemello, C Antona, et al.
Bone Marrow Transplantation
|
January 13, 2015
Focal nodular hyperplasia of the liver: an emerging complication of hematopoietic SCT in children
M Pillon, N S Carucci, C Mainardi, et al.
Gut
|
February 14, 2003
Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase
A B van Nunen, B E Hansen, D J Suh, et al.
Journal of Hepatology
|
May 1, 1996
Epidemiological, clinical and therapeutic associations of hepatitis C types in western European patients
P Simmonds, J Mellor, A Craxi, et al.
Journal of Viral Hepatitis
|
October 15, 2014
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: the International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program
S Bruno, S Bollani, A L Zignego, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 67) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 67 results.
Journal of Viral Hepatitis
|
January 14, 2012
Peginterferon alfa-2b plus weight-based ribavirin for 24 weeks in patients with chronic hepatitis C virus genotype 1 with low viral load who achieve rapid viral response
A Craxi, S Koutsounas, P Ogurtsov, et al.
Gastroenterology
|
July 27, 1999
Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: analysis of individual patient data of six controlled trials. Eurohep Study Group for Viral Hepatitis
S W Schalm, O Weiland, B E Hansen, et al.
Journal of Viral Hepatitis
|
March 1, 1997
Treatment of chronic hepatitis C with interferon-alpha by monitoring the response according to viraemia
P Bonetti, L Chemello, C Antona, et al.
Bone Marrow Transplantation
|
January 13, 2015
Focal nodular hyperplasia of the liver: an emerging complication of hematopoietic SCT in children
M Pillon, N S Carucci, C Mainardi, et al.
Gut
|
February 14, 2003
Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase
A B van Nunen, B E Hansen, D J Suh, et al.
Journal of Hepatology
|
May 1, 1996
Epidemiological, clinical and therapeutic associations of hepatitis C types in western European patients
P Simmonds, J Mellor, A Craxi, et al.
Journal of Viral Hepatitis
|
October 15, 2014
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: the International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program
S Bruno, S Bollani, A L Zignego, et al.
Page
of 7